콘텐츠로 건너뛰기
Merck

1.10317

Millipore

Fractogel® EMD BioSEC (S)

동의어(들):

Fractogel® EMD BioSEC (S)

로그인조직 및 계약 가격 보기


About This Item

UNSPSC 코드:
41115711

ligand

(Modified pore structure)

Quality Level

설명

for size exclusion chromatography (SEC), suspension in 20% ethanol and 150 mM NaCl (20-40 µm)

제품 라인

Fractogel®

파라미터

100 cm/hr max. flow rate
8 bar pressure

기질 활성군

Methacrylate

평균 입자 크기

20-40 μm

전이 온도

flash point 35 °C (calculated)

density

1.43 g/cm3 at 20 °C

응용 분야

viral therapy

분리 기술

size exclusion (SEC)

저장 온도

2-30°C

일반 설명

Size exclusion chromatography for separation of proteins in the range between 5 kDa and 1000 kDa

특징 및 장점

Fractogel® EMD BioSEC (S) enables users to:

  • Effectively remove dimer and high molecular weight aggregates and complete an efficient polishing of blood plasma factors
  • Determine apparent molecular weights of proteins
  • Move predictably and efficiently from bench scale to manufacturing scale processing
  • Create a robust, consistent, and transferable process

포장

Plastic bottle

분석 메모

Appearance: Milky turbid suspension,free from impurities(foreign particles)
Microscopic evaluation: Uniform sphericalparticles, noagglomerates, nofines
Extractable matter (water): ≤ 0.03 %
Cerium: ≤ 1 µg/g
Pressure drop(column: ID=1.6 cm, L=10 cm at 5 ml/min): ≤ 5.0 bar
Particle size (d10): 20 - 28 µm
Particle size (d50): 24 - 34 µm
Particle size (d90): 28 - 38 µm
Colony forming units (TAMC + TYMC): ≤ 100 CFU/ml
Endotoxins: ≤ 1.00 EU/ml
Function test (b:a): ≤ 0.7
function test (c:d): ≤ 0.05
Functional Test: Separation of bovine serum albumin, ovalbumin and cytochrom C

법적 정보

FRACTOGEL is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our 제품 선택기 도구.

픽토그램

Flame

신호어

Warning

유해 및 위험 성명서

Hazard Classifications

Flam. Liq. 3

Storage Class Code

3 - Flammable liquids

WGK

WGK 3

Flash Point (°F)

95.0 °F

Flash Point (°C)

35 °C


시험 성적서(COA)

제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

문서

A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.

Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.

Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.

This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.

관련 콘텐츠

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.